63 related articles for article (PubMed ID: 32536579)
1. Correlation of the levels of DNA-binding inhibitor Id3 and regulatory T cells with SLE disease severity.
Liu C; Yu S; Jin R; Long Y; Lu S; Song Y; Sun X; Sun XH; Zhang Y
J Autoimmun; 2020 Sep; 113():102498. PubMed ID: 32536579
[TBL] [Abstract][Full Text] [Related]
2. The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus.
Golding A; Hasni S; Illei G; Shevach EM
Arthritis Rheum; 2013 Nov; 65(11):2898-906. PubMed ID: 23925905
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.
Wilhelm AJ; Rhoads JP; Wade NS; Major AS
Ann Rheum Dis; 2015 Apr; 74(4):778-85. PubMed ID: 24395554
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting
Ma S; Feng G; Li L; Li Z; Zhou X; Zhou Y; Zhang R
Lupus; 2023 Oct; 32(12):1430-1439. PubMed ID: 37852297
[TBL] [Abstract][Full Text] [Related]
5. Study on the expression changes of lncRNA in patients with systemic lupus erythematosus and its correlation with Treg cells.
Bu YJ; Cen X; Wang YQ; Fan R; Zhang F; Liu YQ; An J; Qiao J; Zhang SX; Chen JW
Clin Rheumatol; 2024 Mar; 43(3):993-1002. PubMed ID: 38253780
[TBL] [Abstract][Full Text] [Related]
6. Cutting Edge: Dynamic Expression of Id3 Defines the Stepwise Differentiation of Tissue-Resident Regulatory T Cells.
Sullivan JM; Höllbacher B; Campbell DJ
J Immunol; 2019 Jan; 202(1):31-36. PubMed ID: 30518568
[TBL] [Abstract][Full Text] [Related]
7. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease.
Miyazaki M; Miyazaki K; Chen S; Itoi M; Miller M; Lu LF; Varki N; Chang AN; Broide DH; Murre C
Nat Immunol; 2014 Aug; 15(8):767-76. PubMed ID: 24973820
[TBL] [Abstract][Full Text] [Related]
8. CD4 T lymphocyte subsets display heterogeneous susceptibility to apoptosis induced by serum from patients with systemic lupus erythematosus.
Mesquita FV; Ferreira V; Mesquita D; Andrade LEC
Adv Rheumatol; 2023 Aug; 63(1):40. PubMed ID: 37587510
[TBL] [Abstract][Full Text] [Related]
9. Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin.
Legorreta-Haquet MV; Chávez-Rueda K; Chávez-Sánchez L; Cervera-Castillo H; Zenteno-Galindo E; Barile-Fabris L; Burgos-Vargas R; Álvarez-Hernández E; Blanco-Favela F
Medicine (Baltimore); 2016 Feb; 95(5):e2384. PubMed ID: 26844452
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor networks in aged naïve CD4 T cells bias lineage differentiation.
Hu B; Li G; Ye Z; Gustafson CE; Tian L; Weyand CM; Goronzy JJ
Aging Cell; 2019 Aug; 18(4):e12957. PubMed ID: 31264370
[TBL] [Abstract][Full Text] [Related]
11. ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis.
Nagasaka M; Miyajima C; Inoue Y; Hashiguchi S; Suzuki Y; Morishita D; Aoki H; Toriuchi K; Katayama R; Aoyama M; Hayashi H
Biochem Biophys Res Commun; 2024 May; 708():149789. PubMed ID: 38513475
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells.
Ratliff ML; Ward JM; Merrill JT; James JA; Webb CF
J Immunol; 2015 Feb; 194(3):940-9. PubMed ID: 25535283
[TBL] [Abstract][Full Text] [Related]
13. High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus.
Maeda S; Hashimoto H; Maeda T; Tamechika SY; Isogai S; Naniwa T; Niimi A
Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37802602
[TBL] [Abstract][Full Text] [Related]
14. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer.
Tsuchiya T; Okaji Y; Tsuno NH; Sakurai D; Tsuchiya N; Kawai K; Yazawa K; Asakage M; Yamada J; Yoneyama S; Kitayama J; Osada T; Watanabe T; Tokunaga K; Takahashi K; Nagawa H
Cancer Sci; 2005 Nov; 96(11):784-90. PubMed ID: 16271072
[TBL] [Abstract][Full Text] [Related]
15. Elevation of Metrnβ and Its Association with Disease Activity in Systemic Lupus Erythematosus.
Zhang C; Cai S; Li Y; Xu X; Liu Y; Qiao H; Wong CK; Wu G; Jin H; Gao X
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686413
[TBL] [Abstract][Full Text] [Related]
16. CD4
Jiang J; Yang M; Zhu H; Long D; He Z; Liu J; He L; Tan Y; Akbar AN; Reddy V; Zhao M; Long H; Wu H; Lu Q
Eur J Immunol; 2024 May; ():e2350603. PubMed ID: 38752316
[TBL] [Abstract][Full Text] [Related]
17. Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity.
Scherlinger M; Pan W; Hisada R; Boulougoura A; Yoshida N; Vukelic M; Umeda M; Krishfield S; Tsokos MG; Tsokos GC
Sci Adv; 2022 Dec; 8(48):eadc9657. PubMed ID: 36449620
[TBL] [Abstract][Full Text] [Related]
18. Estradiol in Systemic Lupus Erythematosus.
Constantin AM; Baicus C
Acta Endocrinol (Buchar); 2023; 19(2):274-276. PubMed ID: 37908893
[TBL] [Abstract][Full Text] [Related]
19. Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.
París-Muñoz A; León-Triana O; Pérez-Martínez A; Barber DF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203623
[TBL] [Abstract][Full Text] [Related]
20. FCRL3 expression is upregulated and closely correlates with TIGIT expression in regulatory T cells of patients with systemic lupus erythematosus.
Bahabayi A; Zhang YH; Yuan Z; Wang Y; Zhang Z; Zeng X; Guan Z; Wang P; Liu C
Eur J Immunol; 2024 May; 54(5):e2350739. PubMed ID: 38461541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
